.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
McKesson
Merck
Express Scripts
Healthtrust
Medtronic
Dow
Moodys
Cantor Fitzgerald

Generated: February 20, 2018

DrugPatentWatch Database Preview

Patents Expiring in March 2022

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-002Feb 29, 2008ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialYMAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-002Feb 29, 2008ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialYFOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-001Feb 29, 2008ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialYFOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-001Feb 29, 2008ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialYMAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-003Aug 20, 2014ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialYFOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION
Wyeth Pharms IncPRISTIQdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL021992-003Aug 20, 2014ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialYMAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-004Jan 18, 2008RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-003Jan 18, 2008RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-002Jan 18, 2008RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-001Jan 18, 2008RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
McKinsey
Cipla
UBS
Queensland Health
Federal Trade Commission
Covington
Julphar
Accenture
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot